Search

Your search keyword '"Pneumocystis carinii pathogenicity"' showing total 120 results

Search Constraints

Start Over You searched for: Descriptor "Pneumocystis carinii pathogenicity" Remove constraint Descriptor: "Pneumocystis carinii pathogenicity"
120 results on '"Pneumocystis carinii pathogenicity"'

Search Results

1. Retracing the evolution of Pneumocystis species, with a focus on the human pathogen Pneumocystis jirovecii .

2. Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients.

3. Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Pneumocystis Innate Immunity.

4. A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.

5. Co-infection of Pneumocystis jirovecii pneumonia and pulmonary CMV in a infant with X-linked severe combined immunodeficiency.

6. Genomic insights into the host specific adaptation of the Pneumocystis genus.

7. Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness.

8. Increased mRNA expression of key cytokines among suspected cases of Pneumocystis jirovecii infection.

9. Pneumocystis jirovecii.

10. Outbreak-Causing Fungi: Pneumocystis jirovecii.

11. On the molecular determinants of the SARS-CoV-2 attack.

12. Humans Are Selectively Exposed to Pneumocystis jirovecii.

13. BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates.

14. Hypercalcemia Heralding Pneumocystis jirovecii Pneumonia in an HIV-Seronegative Patient with Diffuse Cutaneous Systemic Sclerosis.

15. Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients.

16. Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.

18. Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.

19. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.

20. Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests.

21. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.

22. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.

23. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report.

24. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

25. Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention.

26. An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.

27. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.

28. Negative role of malnutrition in cell-mediated immune response: Pneumocystis jirovecii pneumonia (PCP) in a severely malnourished, HIV-negative patient with anorexia nervosa.

29. Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.

30. Mechanisms of Surface Antigenic Variation in the Human Pathogenic Fungus Pneumocystis jirovecii .

31. Comparison of Pneumocystis nucleic acid and antibody profiles and their associations with other respiratory pathogens in two Austrian pig herds.

32. Unusual presentation of combined immunodeficiency in a child with homozygous DOCK8 mutation.

33. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.

34. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.

35. Diagnosis and management of Pneumocystis jirovecii infection.

36. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

37. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.

38. Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool.

40. Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients.

41. Recent Advances in the Diagnosis of Pneumocystis Pneumonia.

42. Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer.

43. Pathology of Sarcoidosis.

44. New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards.

45. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?

46. Single nodular opacity of granulomatous pneumocystis jirovecii pneumonia in an asymptomatic lymphoma patient.

47. Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.

48. Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency.

49. A novel intronic splice site deletion of the IL-2 receptor common gamma chain results in expression of a dysfunctional protein and T-cell-positive X-linked Severe combined immunodeficiency.

50. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.

Catalog

Books, media, physical & digital resources